Aa
Recent articles on HCV
Latest articles about Hepatitis C in
http://www.natap.org/
HCV Section
Increased Rates of Liver Cell Death in HCV/HIV Coinfection - (10/07/05)
Didanosine plus ribavirin can be toxic in HIV patients treated for hepatitis C - (10/07/05)
Toll-Like Receptors: new therapy to stimulate immune system - (10/06/05)
Increased Rates of Liver Cell Death in HCV/HIV Coinfection - (10/05/05)
Biomarkers used to predict recurrent disease in hepatitis C transplant patients - (10/05/05)
24 Week PegIntron/RBV Therapy Approved in Europe for HCV Genotype 1 & Low Viral Load - (10/05/05)
Presence of Hepatitis C Virus (HCV) RNA in the Genital Tracts of HCV/HIV-1-Coinfected Women - (10/05/05)
Undetectable HIV May Slow Fibrosis in HCV/HIV Coinfected Patients - (10/04/05)
New HCV Antisense Drug - (10/04/05)
Hepatitis C Vaccine Candidate - (10/04/05)
Two New HCV Polymerase Inhibitors: early study data show potency & perhaps once daily dosing - (10/04/05)
New HCV Drug NM283 HBV Drug LdT at AASLD - (10/03/05)
New HCV Protease Inhibitor VX-950 - (10/03/05)
Hepatitis C and liver transplantation - (10/03/05)
Breakthrough for HCV research: in vitro HCV replication - (10/03/05)
Asians 'risk fatal liver disease' - (10/03/05)
New HCV & HBV Drugs: XTL-6865, XTL2125 - (09/30/05)
Britain 'failing' on hepatitis C - (09/30/05)
Hepatitis C: Current approaches in pediatrics - (09/30/05)
Noninvasive Fibrosis Test Performs Well - (09/30/05)
New Toll-like Receptor Drug Acti
http://www.natap.org/
HCV Section
Increased Rates of Liver Cell Death in HCV/HIV Coinfection - (10/07/05)
Didanosine plus ribavirin can be toxic in HIV patients treated for hepatitis C - (10/07/05)
Toll-Like Receptors: new therapy to stimulate immune system - (10/06/05)
Increased Rates of Liver Cell Death in HCV/HIV Coinfection - (10/05/05)
Biomarkers used to predict recurrent disease in hepatitis C transplant patients - (10/05/05)
24 Week PegIntron/RBV Therapy Approved in Europe for HCV Genotype 1 & Low Viral Load - (10/05/05)
Presence of Hepatitis C Virus (HCV) RNA in the Genital Tracts of HCV/HIV-1-Coinfected Women - (10/05/05)
Undetectable HIV May Slow Fibrosis in HCV/HIV Coinfected Patients - (10/04/05)
New HCV Antisense Drug - (10/04/05)
Hepatitis C Vaccine Candidate - (10/04/05)
Two New HCV Polymerase Inhibitors: early study data show potency & perhaps once daily dosing - (10/04/05)
New HCV Drug NM283 HBV Drug LdT at AASLD - (10/03/05)
New HCV Protease Inhibitor VX-950 - (10/03/05)
Hepatitis C and liver transplantation - (10/03/05)
Breakthrough for HCV research: in vitro HCV replication - (10/03/05)
Asians 'risk fatal liver disease' - (10/03/05)
New HCV & HBV Drugs: XTL-6865, XTL2125 - (09/30/05)
Britain 'failing' on hepatitis C - (09/30/05)
Hepatitis C: Current approaches in pediatrics - (09/30/05)
Noninvasive Fibrosis Test Performs Well - (09/30/05)
New Toll-like Receptor Drug Acti
Psych Impairment in Coinfected Women - (09/29/05)
Flamel Technologies Announces Positive Preliminary Results of a Phase I/II Trial of IFN-alpha-XL in Patients with Chronic Hepatitis C Virus Infection - (09/29/05)
Chronic Hepatitis C in Latinos: Natural History, Treatment Eligibility, Acceptance, and Outcomes - (09/29/05)
MIGENIX Completes First Clinical Study of Celgosivir in Chronic Hepatitis C Patients - (09/29/05)
Bioenvision's Phase II Trial of Virostat Very Active in Hepatitis C - (09/29/05)
New Hep C Protease Inhibitor - (09/21/05)
Liver Injury and Changes in Hepatitis C Virus (HCV) RNA Load Associated with Protease Inhibitor-Based Antiretroviral Therapy for Treatment-Naive HCV-HIV-Coinfected Patients: Lopinavir-Ritonavir versus Nelfinavir - (
Have an Answer?
You are reading content posted in the Hepatitis C Community
Learn about this treatable virus.
Getting tested for this viral infection.
3 key steps to getting on treatment.
4 steps to getting on therapy.
What you need to know about Hep C drugs.
How the drugs might affect you.
These tips may up your chances of a cure.
A list of national and international resources and hotlines to help connect you to needed health and medical services.
Herpes sores blister, then burst, scab and heal.
Herpes spreads by oral, vaginal and anal sex.
STIs are the most common cause of genital sores.
Condoms are the most effective way to prevent HIV and STDs.
PrEP is used by people with high risk to prevent HIV infection.
